How many times did you hear about "Science Ventures" and then hesitated?
Maybe it is time for you to drill down...
This event will bring Spain's leading financial institutions and professional investors, that have no affinity to health tech, biotech and the rest of the science and innovation based venture sectors. The aim is to introduce and effectively communicate why investing in science ventures may be an excellent alternative for investment.
The objectives of this event are to:
Bring together the Spanish Business Angel Networks’ members in one exclusive event
Bring top European investors and investment professionals from different science and innovation based venture sectors
Enable Spanish investors to attend an exceptional networking event
Make national investors more confident about investing in science ventures
Facilitate the growth of Spanish network of investors
Schedule
17:00
Welcome and opening
Maria Chatzou, President Innovation Forum Barcelona
17:15
Introduction to science and innovation-based entrepreneurship in Catalonia
Albert Barbera, Director of Biocat
17:30
Panel Discussion: The investment challenges entrepreneurs face
Moderator:
Marc Ramis – Serial Entrepreneur & CEO & Co-founder of Senolytic Therapeutics
Panel Speakers: Teresa Tarrago, CEO & Co-founder of Iproteos Laszlo Bax, CEO & Co-founer of Braingaze Davide D’Amico, CEO & Co-founer of ZeClinics Markus Wilhelms, CEO & Co-founder of MowoOT
AlfonsNonell, CEO Mind the Byte
18:15
KEYNOTE: Investing in Healthcare – Opportunities and risks of backing complex science focused companies in regulated sectors
Nick Ibery, Health & Life Sciences Specialist Investor, Senior Advisor to Innovation Forum
18:35
Panel Discussion: The role of investors in the ecosystem
Moderator: Marta Emerson, Vice-President & Co-founder of AMCES
Panel Speakers: Lluis Pareras, Director at HealthEquity SCR Xavier Pont, Co-founder of Ship2B Ignacio Fonts, Managing Partner at Inveready Josep Mora, Managing Director at Idodi Venture Capital Sara Ylipoti, COO at Conector Accelerator
19:15
KEYNOTE: What VCs are looking for in a science-based venture
Josep Sanfeliu, General Partner at Ysios Venture Capital
19:30
KEYNOTE: What big pharma is looking for in order to invest in or partner with science-based ventures
Dr Ann Connolly, Senior Director of New Ventures at Johnson & Johnson Innovation
We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. By continuing to use our services, you are giving us your consent to use cookies. Learn more here.